Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q1 2026 Earnings Call Transcript

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q1 2026 Earnings Call Transcript May 12, 2026

Atea Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.57, expectations were $-0.6.

Operator: Ladies and gentlemen, thank you for standing by. Welcome to Atea Pharmaceuticals’ First Quarter 26 Earnings Conference Call. At this time, participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. I will now turn it over to Atea’s...